|
On the definition and the computation of the basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populations
|
journal
|
June 1990 |
|
On a new perspective of the basic reproduction number in heterogeneous environments
|
journal
|
August 2011 |
|
Mass concentration in a nonlocal model of clonal selection
|
journal
|
March 2016 |
|
Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy
|
journal
|
May 2017 |
|
Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue
|
journal
|
February 2018 |
|
Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia Through Mathematical Modelling
|
journal
|
July 2020 |
|
Persister cells and tolerance to antimicrobials
|
journal
|
January 2004 |
|
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation
|
journal
|
November 2016 |
|
Tumor heterogeneity: Causes and consequences
|
journal
|
January 2010 |
|
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|
journal
|
April 2010 |
|
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
|
journal
|
August 2011 |
|
Memory Sequencing Reveals Heritable Single-Cell Gene Expression Programs Associated with Distinct Cellular Behaviors
|
journal
|
August 2020 |
|
Endogenous Replication Stress in Mother Cells Leads to Quiescence of Daughter Cells
|
journal
|
May 2017 |
|
Prolonged Prometaphase Blocks Daughter Cell Proliferation Despite Normal Completion of Mitosis
|
journal
|
September 2010 |
|
Bet-hedging in stochastically switching environments
|
journal
|
November 2013 |
|
Understanding the role of phenotypic switching in cancer drug resistance
|
journal
|
April 2020 |
|
Toward understanding of the role of reversibility of phenotypic switching in the evolution of resistance to therapy
|
journal
|
June 2018 |
|
The evolution of bet-hedging adaptations to rare scenarios
|
journal
|
December 2007 |
|
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
|
journal
|
May 2015 |
|
Dynamics of multiple myeloma tumor therapy with a recombinant measles virus
|
journal
|
June 2009 |
|
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
|
journal
|
June 2017 |
|
Competing memories of mitogen and p53 signalling control cell-cycle entry
|
journal
|
September 2017 |
|
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
|
journal
|
February 2016 |
|
Non-Darwinian dynamics in therapy-induced cancer drug resistance
|
journal
|
September 2013 |
|
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
|
journal
|
February 2015 |
|
Understanding and targeting resistance mechanisms in NSCLC
|
journal
|
October 2017 |
|
Cancer drug resistance: an evolving paradigm
|
journal
|
September 2013 |
|
Turning ecology and evolution against cancer
|
journal
|
April 2014 |
|
The mathematics of cancer: integrating quantitative models
|
journal
|
November 2015 |
|
Tumour heterogeneity and resistance to cancer therapies
|
journal
|
November 2017 |
|
Persister cells, dormancy and infectious disease
|
journal
|
December 2006 |
|
Spatial competition constrains resistance to targeted cancer therapy
|
journal
|
December 2017 |
|
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
|
journal
|
November 2017 |
|
Age structure landscapes emerge from the equilibrium between aging and rejuvenation in bacterial populations
|
journal
|
September 2018 |
|
Hidden heterogeneity and circadian-controlled cell fate inferred from single cell lineages
|
journal
|
December 2018 |
|
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
|
journal
|
May 2020 |
|
Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer
|
journal
|
February 2019 |
|
Cooperation among cancer cells: applying game theory to cancer
|
journal
|
November 2018 |
|
Rapid phenotypic individualization of bacterial sister cells
|
journal
|
August 2017 |
|
Neighborhood size-effects shape growing population dynamics in evolutionary public goods games
|
journal
|
February 2019 |
|
Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells
|
journal
|
September 2009 |
|
The Cell Cycle Switch Computes Approximate Majority
|
journal
|
September 2012 |
|
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
|
journal
|
December 2017 |
|
Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance
|
journal
|
August 2013 |
|
Model genotype–phenotype mappings and the algorithmic structure of evolution
|
journal
|
November 2019 |
|
Genotype–phenotype mapping and the end of the ‘genes as blueprint’ metaphor
|
journal
|
February 2010 |
|
Global microRNA depletion suppresses tumor angiogenesis
|
journal
|
May 2014 |
|
Density Dependence and Cooperation: Theory and a test with Bacteria
|
journal
|
September 2009 |
|
Bacterial Persistence as a Phenotypic Switch
|
journal
|
September 2004 |
|
Mechanisms of bacterial persistence during stress and antibiotic exposure
|
journal
|
December 2016 |
|
Temporal integration of mitogen history in mother cells controls proliferation of daughter cells
|
journal
|
April 2020 |
|
Adaptive Therapy
|
journal
|
June 2009 |
|
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
|
journal
|
April 2015 |
|
Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
|
journal
|
January 2015 |
|
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies
|
journal
|
January 2018 |
|
Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel
|
journal
|
March 2004 |
|
Evolutionary Determinants of Cancer
|
journal
|
July 2015 |
|
Morphisms of reaction networks that couple structure to function
|
journal
|
January 2014 |
|
Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations
|
journal
|
August 2016 |
|
Bistability in a Metabolic Network Underpins the De Novo Evolution of Colony Switching in Pseudomonas fluorescens
|
journal
|
March 2015 |
|
Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways
|
journal
|
March 2019 |
|
Competing evolutionary paths in growing populations with applications to multidrug resistance
|
journal
|
April 2019 |
|
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer
|
journal
|
August 2019 |
|
Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging
|
journal
|
December 2016 |
|
Cancer statistics, 2018: Cancer Statistics, 2018
|
journal
|
January 2018 |
|
Equivalences between age structured models and state dependent distributed delay differential equations
|
journal
|
January 2019 |